Solventum Corporation (NYSE:SOLV) ranks among the recent spin-off companies that hedge funds are piling into. On March 20, CIBC reiterated its Outperformer rating on Solventum Corporation (NYSE:SOLV) and its $37 price target. The firm believes the company’s 2026 forecast, which is slightly higher than consensus estimates, includes some caution, notably on gross margins. CIBC stated that management might use increased balance sheet capacity for mergers and acquisitions to increase scale, footprint, and se ...